Advertisement
Advertisement

KALA

KALA logo

KALA BIO, Inc. Common Stock

0.08
USD
Sponsored
0.00
-4.57%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

0.08

0.00
-2.27%

KALA BIO, Inc. Common Stock Profile

About

KALA BIO is a clinical-stage biopharmaceutical company. It focused on the research, development and commercialization of therapies for rare and severe diseases of the eye. The company' s lead product candidate consists KPI-012. KALA BIO, formerly known as Kala Pharmaceuticals Inc., is based in ARLINGTON, Mass.

Info & Links

CEO

Avi Minkowitz

Headquarters

1167 MASSACHUSETTS AVENUE
ARLINGTON, MA 02476, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.kalarx.com

Auditor

Deloitte & Touche LLP

Share holders

40

Employees

6

KALA BIO, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

72.04M

Enterprise Value

64.48M

Enterprise Value/EBITDA(ttm)

-1.63

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-2323.94%

Return on Invested Capital(ttm)

-31.41%

Return on Assets(ttm)

-86.99%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-39.51M

Net Income Available to Common(ttm)

-26.98M

Diluted EPS(ttm)

-5.93

Share Statistics

Beta (5Y Monthly)

-1.98

52-Week Change

-97.69%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

929.49M

Dividend Yield

0.00%

Float4

890.92M

% Held by Insiders

2.24%

% Held by Institutions

24.61%

Balance Sheet

Total Cash(mrq)

7.56M

Total Cash Per Share(mrq)

0.01

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

-327.88%

Current Ratio(mrq)

0.75%

Quick Ratio(mrq)

0.75%

Book Value Per Share(mrq)

-1.17

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.90

Free Cash Flow(ytd)

-27.45M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement